Prospects for the development of pharmacogenetics in Russia for the personalization of pharmacotherapy-Reference-Cited by-同舟云学术

Prospects for the development of pharmacogenetics in Russia for the personalization of pharmacotherapy

Published:2023-11-23 Issue:5 Volume:3 Page:39-45
ISSN:2782-3814
Container-title:Russian Journal for Personalized Medicine
language:
Short-container-title:jour

Author:

Sychev D. A.¹,Mirzaev K. B.¹,Denisenko N. P.¹

Affiliation:

1. Russian Medical Academy of Continuous Professional Education

Abstract

The article presents the concept of development of research in the field of pharmacogenetics and personalized medicine in the Russian Federation and ways of introducing “omics” technologies into widespread clinical practice.

Publisher

Arterialnaya Gipertenziya

Reference29 articles.

1. Khokhlov AL, Sychev DA. The concept of patient-oriented medicine and pharmacy. Russ J Patient-Oriented Medicine and Pharmacy. 2023; 1(1):1–4. (In Russian) DOI: 10.37489/2949-1924-0001.

2. Стратегия научно-технологического развития Российской Федерации (утв. Указом Президента РФ от 01.12.2016 № 642).

3. Стратегия развития здравоохранения в Российской Федерации на период до 2025 года (утв. Указом Президента РФ от 06.06.2019 № 254).

4. Федеральная научно-техническая программа развития генетических технологий на 2019–2027 годы (Постановление от 22.04.2019 № 479).

5. Moshetova LK, Soshina MM, Turkina KI, et al. Effect of CYP2D6*4, CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma. Drug Metab Pers Ther. 2022; 38(2):143–148. DOI: 10.1515/dmpt-2022-0117.